Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roehrborn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annual Review of Medicine|January 1, 1997
Management of benign prostatic hyperplasiaM Barry, C Roehrborn
Urology|March 29, 2000
Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasiaP Boyle, C Robertson, F Lowe, et al.
BJU International|March 31, 2004
Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasiaP Boyle, C Robertson, F Lowe, et al.
The Journal of Urology|December 14, 2012
Evaluation and treatment of lower urinary tract symptoms in older menP Abrams, C Chapple, S Khoury, et al.
The Journal of Urology|February 24, 2009
Evaluation and treatment of lower urinary tract symptoms in older menP Abrams, C Chapple, S Khoury, et al.
BJU International|July 31, 2003
Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitorM P O'Leary, C Roehrborn, G Andriole, et al.
European Urology|April 15, 2004
5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgeryP Boyle, C Roehrborn, R Harkaway, et al.
Urology|September 8, 2004
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasiaG L Andriole, C Roehrborn, C Schulman, et al.
Prostate Cancer and Prostatic Diseases|September 14, 2011
Prevalence of BPH and lower urinary tract symptoms in West AfricansA P Chokkalingam, E D Yeboah, A Demarzo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annual Review of Medicine|January 1, 1997
Management of benign prostatic hyperplasiaM Barry, C Roehrborn
Urology|March 29, 2000
Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasiaP Boyle, C Robertson, F Lowe, et al.
BJU International|March 31, 2004
Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasiaP Boyle, C Robertson, F Lowe, et al.
The Journal of Urology|December 14, 2012
Evaluation and treatment of lower urinary tract symptoms in older menP Abrams, C Chapple, S Khoury, et al.
The Journal of Urology|February 24, 2009
Evaluation and treatment of lower urinary tract symptoms in older menP Abrams, C Chapple, S Khoury, et al.
BJU International|July 31, 2003
Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitorM P O'Leary, C Roehrborn, G Andriole, et al.
European Urology|April 15, 2004
5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgeryP Boyle, C Roehrborn, R Harkaway, et al.
Urology|September 8, 2004
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasiaG L Andriole, C Roehrborn, C Schulman, et al.
Prostate Cancer and Prostatic Diseases|September 14, 2011
Prevalence of BPH and lower urinary tract symptoms in West AfricansA P Chokkalingam, E D Yeboah, A Demarzo, et al.
Pageof 1